Bharat Biotech International Ltd. introduced their new product 'Hillchol', a novel single-strain oral cholera vaccine, on Tuesday.
Bharat Biotech developed Hillchol (BBV131) to combat cholera under license from Hilleman Laboratories, which receive funding from Merck USA and Wellcome Trust.
Global demand for oral cholera vaccines, or OCVs, exceeds 100 million doses annually, making them crucial for cholera control. There is a global shortage of OCVs as there is only one manufacturer.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
BBIL has established large-scale manufacturing facilities in Hyderabad and Bhubaneswar with a capacity to produce up to 200 million doses of Hillchol, it further said.
A multi-stage, clinical evolution process culminating in a phase 3 study confirmed the vaccine's safety, immunogenicity, and non-inferiority to existing OCVs, establishing its potential for white spirit, public health use.
The vaccine, a single dose respule, is meant to be administered orally on days 0 and 14 and is suitable for those above the age of one.
(With Inputs From PTI)
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
